Cell Culture Process Scale-Up Challenges for Commercial-Scale Manufacturing of Allogeneic Pluripotent Stem Cell Products
This publication examines critical upstream manufacturing challenges associated with scaling pluripotent stem cell cultures for commercial allogeneic cell therapy production. The paper evaluates key process variables including seed train generation, hydrodynamic conditions, aggregate morphology control, oxygen transfer, carbon dioxide removal, medium exchange, and cell harvest operations. Computational fluid dynamics and experimental studies demonstrate how energy dissipation rate can be used as a predictive scale-up parameter to maintain uniform aggregate morphology across bioreactor scales. The authors also propose strategies for oxygenation and scalable media exchange that minimize process bottlenecks for sensitive aggregate cultures. The article provides practical engineering frameworks for developing robust large-scale manufacturing processes while maintaining pluripotency and therapeutic cell quality.
The PBS Closed-System Sampling Conical is designed to simplify aseptic bioreactor sampling while helping maintain process integrity and sample…
This protocol provides step-by-step guidance for forming and expanding pluripotent stem cell aggregates in PBS-MINI Vertical-Wheel bioreactors.
This poster presents a three-dimensional bioprocess for linear scale-up of human induced pluripotent stem cell expansion from 0.1 L through an 80…
How Can We Help?
Tell us what you need and we’ll take it from there.